Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A mesenchymal chondrosarcoma occurring in children.
Biomarker and diagnostic research for pediatric mesenchymal chondrosarcoma has been reported in the published literature.
4 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 3 PHASE2. Research is primarily sponsored by academic and government institutions.
51 publications have been identified in PubMed for pediatric mesenchymal chondrosarcoma. Research spans Case Report / Case Series (55%), Review / Meta-Analysis (16%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 27 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 7:49 AM UTC
55%
Research summaries | 8 | 16% |
Disease patterns and progression | 5 | 10% |
New treatment approaches | 4 | 8% |
Clinical study results | 2 | 4% |
Laboratory research | 2 | 4% |
Testing and diagnosis research | 1 | 2% |
Nagy A (2026). [PMID: 41930936](https://pubmed.ncbi.nlm.nih.gov/41930936/). *Adv Anat Pathol*. [Diagnostic / Biomarker]
Baldi GG (2026). [PMID: 41650748](https://pubmed.ncbi.nlm.nih.gov/41650748/). *ESMO open*. [Gene Therapy / Novel Therapeutics]
Çalışkan Kamış Ş (2026). [PMID: 41867924](https://pubmed.ncbi.nlm.nih.gov/41867924/). *Front Pediatr*. [Case Report / Case Series]
Ichikawa J (2026). [PMID: 41941232](https://pubmed.ncbi.nlm.nih.gov/41941232/). *Clin Nucl Med*. [Case Report / Case Series]
Leal Lopez A (2026). [PMID: 41731714](https://pubmed.ncbi.nlm.nih.gov/41731714/). *International journal of surgical pathology*. [Case Report / Case Series]
Persons JE (2026). [PMID: 41855049](https://pubmed.ncbi.nlm.nih.gov/41855049/). *J Neuropathol Exp Neurol*. [Case Report / Case Series]
Cueva-Cañolaa LE (2025). [PMID: 41027068](https://pubmed.ncbi.nlm.nih.gov/41027068/). *Oral oncology*. [Case Report / Case Series]
Kobayashi H (2025). [PMID: 40483718](https://pubmed.ncbi.nlm.nih.gov/40483718/). *Japanese journal of clinical oncology*. [Epidemiology / Natural History]
Milacek C (2025). [PMID: 41424163](https://pubmed.ncbi.nlm.nih.gov/41424163/). *Therapeutic advances in respiratory disease*. [Review / Meta-Analysis]
Trimukhe A (2025). [PMID: 40614571](https://pubmed.ncbi.nlm.nih.gov/40614571/). *Oral oncology*. [Case Report / Case Series]
AI-curated news mentioning pediatric mesenchymal chondrosarcoma
Updated Feb 5, 2026
A multicentre retrospective analysis by the Italian Sarcoma Group evaluates the activity of chemotherapy in mesenchymal chondrosarcoma. This study provides insights into treatment efficacy for this rare sarcoma subtype.